Search - tctmd.com

Displaying 201 - 220 of 341

Sort: Relevancy | Date

Presentation TCT 2017

Czech Republic Comments: How Would I Treat This Case and Why?

Presenter: Petr Kala, Jochen Wöhrle, Marian Branny

October 30, 2017

Presentation TCT 2017

The BIOMODEX 3D-printed Patient Specific Models for Interventional Cardiology Planification

Presenter: Nicolo Piazza, Josep Rodés-Cabau, Thomas Marchand

October 30, 2017

Presentation TCT 2017

How Did I Treat This Patient?

Presenter: Afzalur Rahman, Chris Kwok Yiu Wong

October 30, 2017

Presentation TCT 2017

Poland Presents: Case Introduction - A Patient With Critical Coronary Disease and Severe Aortic Stenosis

Presenter: Petr Kala, Jochen Wöhrle, Dariusz Dudek

October 30, 2017

Presentation TCT 2017

How Should We Treat This Patient?

Presenter: Afzalur Rahman, Chris Kwok Yiu Wong

October 30, 2017

Presentation TCT 2017

Bangladesh Presents a Case: Left Main Bifurcation

Presenter: Afzalur Rahman, Chris Kwok Yiu Wong

October 30, 2017

Presentation TCT 2017

Slovakia Presents: Current Knowledge Impact of Coronary Artery Disease on TAVR Management and Outcomes

Presenter: Petr Kala, Jochen Wöhrle, Martin Hudec

October 30, 2017

Presentation TCT 2017

Introduction and Session Objectives

Presenter: Afzalur Rahman, Chris Kwok Yiu Wong

October 30, 2017

News Opinion Off Script TCT 2017

Off Script: Welcome to TCT 2017 in the Mile High City

Kwan S. Lee

October 29, 2017

Presentation TCT 2017

Bioresorbable Scaffolds and Outcomes 2017

Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Jochen Wöhrle

October 29, 2017

Presentation TCT 2017

Clinical Case #2: A TAVR Procedure You Dont See Everyday

Presenter: Alejandro Cherro, Alfredo E. Rodriguez, Daniel H. Berrocal

October 29, 2017

Presentation TCT 2017

Drug-Eluting Stent Thrombosis and Restenosis: Mechanisms, Frequency, and Treatment

Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Binita Shah

October 29, 2017

Presentation TCT 2017

Fifteen Years After the First TAVR, Where Are We and Where Are We Headed?

Presenter: Alejandro Cherro, Alfredo E. Rodriguez, Martin B. Leon

October 29, 2017

Presentation TCT 2017

Clinical Case #1: The Limitless Potential of PCI

Presenter: Alejandro Cherro, Alfredo E. Rodriguez, Claudio M Cigalini

October 29, 2017

Presentation TCT 2017

Drug-Eluting Stent Platforms and Outcomes 2017

Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Gennaro Sardella

October 29, 2017

Presentation TCT 2017

Forty Years After the First PCI, Where Are We and Where Are We Headed?

Presenter: Alejandro Cherro, Alfredo E. Rodriguez, Spencer B. King III

October 29, 2017

Presentation TCT 2017

Atherotomy, Atherectomy (Rotational, Orbital, Laser), and Embolic Protection

Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Robert T. Pyo

October 29, 2017

Presentation TCT 2017

Cerebral Protection During TAVR: Routine vs Selective Use

Presenter: David Hildick-Smith, Lars Sondergaard, Axel Linke

October 29, 2017

Presentation TCT 2017

Interventional Pharmacology Strategies for PCI and ACS

Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Piera Capranzano

October 29, 2017

Presentation TCT 2017

LAA Closure: Underused Therapy in Patients With High Bleeding Risk

Presenter: David Hildick-Smith, Lars Sondergaard, Robert A. Byrne

October 29, 2017

Advertisement

Czech Republic Comments: How Would I Treat This Case and Why?

The BIOMODEX 3D-printed Patient Specific Models for Interventional Cardiology Planification

How Did I Treat This Patient?

Poland Presents: Case Introduction - A Patient With Critical Coronary Disease and Severe Aortic Stenosis

How Should We Treat This Patient?

Bangladesh Presents a Case: Left Main Bifurcation

Slovakia Presents: Current Knowledge Impact of Coronary Artery Disease on TAVR Management and Outcomes

Introduction and Session Objectives

Off Script: Welcome to TCT 2017 in the Mile High City

Bioresorbable Scaffolds and Outcomes 2017

Clinical Case #2: A TAVR Procedure You Dont See Everyday

Drug-Eluting Stent Thrombosis and Restenosis: Mechanisms, Frequency, and Treatment

Fifteen Years After the First TAVR, Where Are We and Where Are We Headed?

Clinical Case #1: The Limitless Potential of PCI

Drug-Eluting Stent Platforms and Outcomes 2017

Forty Years After the First PCI, Where Are We and Where Are We Headed?

Atherotomy, Atherectomy (Rotational, Orbital, Laser), and Embolic Protection

Cerebral Protection During TAVR: Routine vs Selective Use

Interventional Pharmacology Strategies for PCI and ACS

LAA Closure: Underused Therapy in Patients With High Bleeding Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content